ArticleNational science review2022

A CRISPR/Cas12a-empowered surface plasmon resonance platform for rapid and specific diagnosis of the Omicron variant of SARS-CoV-2.

Zhi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.